Shunsuke Yamane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shunsuke Yamane has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Nobuya Inagaki
Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University 1
4 shared publications - Norio Harada
Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University 1
2 shared publications Akihiro Hamasaki
1 shared publication- Erina Joo
Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan
1 shared publication - Fumika Mano
Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan
1 shared publication - Kana Yamamoto
Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan
1 shared publication
Latest Publications
- Open Access
Intestinal Morphology and Glucose Transporter Gene Expression under a Chronic Intake of High Sucrose
Sucrose is a disaccharide that is degraded into fructose and glucose in the small intestine. High-sucrose and high-fructose diets have been reported, using two-dimensional imaging, to alter the intestinal morphology and the expression of genes associated with sugar transport, such as sodium glucose co-transporter 1 (SGLT1), glucose transporter 2 (GLUT2), and glucose transporter 5 (GLUT5). However, it remains unclear how high-fructose and high-sucrose diets affect the expression of sugar transporters and the intestinal morphology in the whole intestine. We investigate the influence of a chronic high-sucrose diet on the expression of the genes associated with sugar transport as well as its effects on the intestinal morphology using 3D imaging. High sucrose was found to increase GLUT2 and GLUT5 mRNA levels without significant changes in the intestinal morphology using 3D imaging. On the other hand, the delay in sucrose absorption by an α-glucosidase inhibitor significantly improved the intestinal morphology and the expression levels of SGLT1, GLUT2, and GLUT5 mRNA in the distal small intestine to levels similar to those in the proximal small intestine, thereby improving glycemic control after both glucose and sucrose loading. These results reveal the effects of chronic high-sugar exposure on glucose absorption and changes in the intestinal morphology.
Open AccessIntestinal Morphology and Glucose Transporter Gene Expression under a Chronic Intake of High Sucrose
Sucrose is a disaccharide that is degraded into fructose and glucose in the small intestine. High-sucrose and high-fructose diets have been reported, using two-dimensional imaging, to alter the intestinal morphology and the expression of genes associated with sugar transport, such as sodium glucose co-transporter 1 (SGLT1), glucose transporter 2 (GLUT2), and glucose transporter 5 (GLUT5). However, it remains unclear how high-fructose and high-sucrose diets affect the expression of sugar transporters and the intestinal morphology in the whole intestine. We investigate the influence of a chronic high-sucrose diet on the expression of the genes associated with sugar transport as well as its effects on the intestinal morphology using 3D imaging. High sucrose was found to increase GLUT2 and GLUT5 mRNA levels without significant changes in the intestinal morphology using 3D imaging. On the other hand, the delay in sucrose absorption by an α-glucosidase inhibitor significantly improved the intestinal morphology and the expression levels of SGLT1, GLUT2, and GLUT5 mRNA in the distal small intestine to levels similar to those in the proximal small intestine, thereby improving glycemic control after both glucose and sucrose loading. These results reveal the effects of chronic high-sugar exposure on glucose absorption and changes in the intestinal morphology.
- Open Access
The Effect of White Rice and White Bread as Staple Foods on Gut Microbiota and Host Metabolism
The purpose of this study was to examine the influence of two kinds of major Japanese staple foods, white rice and white bread, on gut microbiota against the background in which participants eat common side dishes. Seven healthy subjects completed the dietary intervention with two 1-week test periods with a 1-week wash-out period in cross-over design (UMIN registration UMIN000023142). White bread or white rice and 21 frozen prepared side dishes were consumed during the test periods. At baseline and at the end of each period, fasting blood samples, breath samples, and fecal samples were collected. For fecal samples, 16S rRNA gene sequencing was used to analyze the gut microbiota. After the bread period, the abundance of fecal Bifidobacterium genus (19.2 ± 14.5 vs. 6.2 ± 6.6 (%), p = 0.03), fasting glucagon-like peptide 1 (GLP-1) (13.6 ± 2.0 vs. 10.5 ± 2.9 (pg/mL), p = 0.03), and breath hydrogen (23.4 ± 9.9 vs. 8.2 ± 5.5 (ppm), p = 0.02) were significantly higher than those of after the rice period. Plasma SCFAs also tended to be higher after the bread period. White bread contains more dietary fiber than refined short grain rice. These findings suggest that indigestible carbohydrate intake from short grain rice as a staple food may be smaller than that of white bread.
Open AccessThe Effect of White Rice and White Bread as Staple Foods on Gut Microbiota and Host Metabolism
The purpose of this study was to examine the influence of two kinds of major Japanese staple foods, white rice and white bread, on gut microbiota against the background in which participants eat common side dishes. Seven healthy subjects completed the dietary intervention with two 1-week test periods with a 1-week wash-out period in cross-over design (UMIN registration UMIN000023142). White bread or white rice and 21 frozen prepared side dishes were consumed during the test periods. At baseline and at the end of each period, fasting blood samples, breath samples, and fecal samples were collected. For fecal samples, 16S rRNA gene sequencing was used to analyze the gut microbiota. After the bread period, the abundance of fecal Bifidobacterium genus (19.2 ± 14.5 vs. 6.2 ± 6.6 (%), p = 0.03), fasting glucagon-like peptide 1 (GLP-1) (13.6 ± 2.0 vs. 10.5 ± 2.9 (pg/mL), p = 0.03), and breath hydrogen (23.4 ± 9.9 vs. 8.2 ± 5.5 (ppm), p = 0.02) were significantly higher than those of after the rice period. Plasma SCFAs also tended to be higher after the bread period. White bread contains more dietary fiber than refined short grain rice. These findings suggest that indigestible carbohydrate intake from short grain rice as a staple food may be smaller than that of white bread.
- 1 May 2012
- Vol. 70 (5) , 846-51
[Clinical biomarkers for diabetes mellitus].
Diabetes mellitus is a group of diseases associated with various metabolic disorders, the main feature of which is chronic hyperglycemia due to insufficient insulin action. Confirmation of chronic hyperglycemia is essential for the diagnosis of diabetes. HbA1c level is considered an indicator of the average blood glucose level over the last 1 to 2 months. According to the recent revision of diagnosis criteria for diabetes, in addition to the earlier listed plasma glucose values, HbA1c has been given a more prominent position as one of the criteria for diabetic diagnosis. Other biomarkers such as glycoalbumin and 1.5-Anhydro-D-glucitol are also useful for evaluating glycemic control. In this chapter, we provide an overview of each clinical biomarkers for diabetes.
- 1 May 2012
- Vol. 70 (5) , 846-51
[Clinical biomarkers for diabetes mellitus].
Diabetes mellitus is a group of diseases associated with various metabolic disorders, the main feature of which is chronic hyperglycemia due to insufficient insulin action. Confirmation of chronic hyperglycemia is essential for the diagnosis of diabetes. HbA1c level is considered an indicator of the average blood glucose level over the last 1 to 2 months. According to the recent revision of diagnosis criteria for diabetes, in addition to the earlier listed plasma glucose values, HbA1c has been given a more prominent position as one of the criteria for diabetic diagnosis. Other biomarkers such as glycoalbumin and 1.5-Anhydro-D-glucitol are also useful for evaluating glycemic control. In this chapter, we provide an overview of each clinical biomarkers for diabetes.
- 29 February 2008
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 79, S68-S69
P-37 Usefulness of C-peptide value for estimating pancreatic β-cell function: Application to the assessment of insulin therapy for Type 2 diabetes
- 29 February 2008
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 79, S68-S69
P-37 Usefulness of C-peptide value for estimating pancreatic β-cell function: Application to the assessment of insulin therapy for Type 2 diabetes